Clinical Trial Update: Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating lixisenatide in patients with Parkinson's disease has completed. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Adlyxin (lixisenatide)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED